Bodybuilding, drugs and risk
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
London [u.a.]
Routledge
2001
|
| Ausgabe: | 1. publ. |
| Schriftenreihe: | Health, risk and society
|
| Schlagworte: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV014186783 | ||
| 003 | DE-604 | ||
| 005 | 20020726 | ||
| 007 | t | ||
| 008 | 020306s2001 |||| 00||| eng d | ||
| 020 | |a 0415226821 |9 0-415-22682-1 | ||
| 020 | |a 041522683X |9 0-415-22683-X | ||
| 035 | |a (OCoLC)44905094 | ||
| 035 | |a (DE-599)BVBBV014186783 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-703 |a DE-355 | ||
| 050 | 0 | |a RC1230 | |
| 082 | 0 | |a 362.29/088/796 |2 21 | |
| 084 | |a ZX 9420 |0 (DE-625)158516:14257 |2 rvk | ||
| 100 | 1 | |a Monaghan, Lee F. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Bodybuilding, drugs and risk |c Lee F. Monaghan |
| 250 | |a 1. publ. | ||
| 264 | 1 | |a London [u.a.] |b Routledge |c 2001 | |
| 300 | |a XIV, 213 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Health, risk and society | |
| 650 | 7 | |a Anabole steroïden |2 gtt | |
| 650 | 4 | |a Anabolisants | |
| 650 | 7 | |a Bodybuilding |2 gtt | |
| 650 | 4 | |a Culturistes - Usage des médicaments | |
| 650 | 4 | |a Dopage dans les sports | |
| 650 | 7 | |a Drugsgebruik |2 gtt | |
| 650 | 7 | |a Lichamelijkheid |2 gtt | |
| 650 | 7 | |a Sociale identiteit |2 gtt | |
| 650 | 4 | |a Anabolic Agents |x adverse effects | |
| 650 | 4 | |a Anabolic steroids | |
| 650 | 4 | |a Bodybuilders |x Drug use | |
| 650 | 4 | |a Doping in Sports | |
| 650 | 4 | |a Doping in sports | |
| 650 | 4 | |a Risk Assessment | |
| 650 | 4 | |a Weight Lifting |x physiology | |
| 650 | 4 | |a Weight Lifting |x psychology | |
| 650 | 0 | 7 | |a Doping |0 (DE-588)4126002-8 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Doping |0 (DE-588)4126002-8 |D s |
| 689 | 0 | |5 DE-604 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-009724379 | ||
Datensatz im Suchindex
| _version_ | 1804129065534226432 |
|---|---|
| any_adam_object | |
| author | Monaghan, Lee F. |
| author_facet | Monaghan, Lee F. |
| author_role | aut |
| author_sort | Monaghan, Lee F. |
| author_variant | l f m lf lfm |
| building | Verbundindex |
| bvnumber | BV014186783 |
| callnumber-first | R - Medicine |
| callnumber-label | RC1230 |
| callnumber-raw | RC1230 |
| callnumber-search | RC1230 |
| callnumber-sort | RC 41230 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | ZX 9420 |
| ctrlnum | (OCoLC)44905094 (DE-599)BVBBV014186783 |
| dewey-full | 362.29/088/796 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 362 - Social problems and services to groups |
| dewey-raw | 362.29/088/796 |
| dewey-search | 362.29/088/796 |
| dewey-sort | 3362.29 288 3796 |
| dewey-tens | 360 - Social problems and services; associations |
| discipline | Sport Soziologie |
| edition | 1. publ. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01648nam a2200553 c 4500</leader><controlfield tag="001">BV014186783</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20020726 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">020306s2001 |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0415226821</subfield><subfield code="9">0-415-22682-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">041522683X</subfield><subfield code="9">0-415-22683-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)44905094</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV014186783</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC1230</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">362.29/088/796</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">ZX 9420</subfield><subfield code="0">(DE-625)158516:14257</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Monaghan, Lee F.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Bodybuilding, drugs and risk</subfield><subfield code="c">Lee F. Monaghan</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. publ.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London [u.a.]</subfield><subfield code="b">Routledge</subfield><subfield code="c">2001</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIV, 213 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Health, risk and society</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anabole steroïden</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anabolisants</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bodybuilding</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Culturistes - Usage des médicaments</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dopage dans les sports</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugsgebruik</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Lichamelijkheid</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sociale identiteit</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anabolic Agents</subfield><subfield code="x">adverse effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anabolic steroids</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bodybuilders</subfield><subfield code="x">Drug use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Doping in Sports</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Doping in sports</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Risk Assessment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Weight Lifting</subfield><subfield code="x">physiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Weight Lifting</subfield><subfield code="x">psychology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Doping</subfield><subfield code="0">(DE-588)4126002-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Doping</subfield><subfield code="0">(DE-588)4126002-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-009724379</subfield></datafield></record></collection> |
| id | DE-604.BV014186783 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T18:59:13Z |
| institution | BVB |
| isbn | 0415226821 041522683X |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-009724379 |
| oclc_num | 44905094 |
| open_access_boolean | |
| owner | DE-703 DE-355 DE-BY-UBR |
| owner_facet | DE-703 DE-355 DE-BY-UBR |
| physical | XIV, 213 S. |
| publishDate | 2001 |
| publishDateSearch | 2001 |
| publishDateSort | 2001 |
| publisher | Routledge |
| record_format | marc |
| series2 | Health, risk and society |
| spelling | Monaghan, Lee F. Verfasser aut Bodybuilding, drugs and risk Lee F. Monaghan 1. publ. London [u.a.] Routledge 2001 XIV, 213 S. txt rdacontent n rdamedia nc rdacarrier Health, risk and society Anabole steroïden gtt Anabolisants Bodybuilding gtt Culturistes - Usage des médicaments Dopage dans les sports Drugsgebruik gtt Lichamelijkheid gtt Sociale identiteit gtt Anabolic Agents adverse effects Anabolic steroids Bodybuilders Drug use Doping in Sports Doping in sports Risk Assessment Weight Lifting physiology Weight Lifting psychology Doping (DE-588)4126002-8 gnd rswk-swf Doping (DE-588)4126002-8 s DE-604 |
| spellingShingle | Monaghan, Lee F. Bodybuilding, drugs and risk Anabole steroïden gtt Anabolisants Bodybuilding gtt Culturistes - Usage des médicaments Dopage dans les sports Drugsgebruik gtt Lichamelijkheid gtt Sociale identiteit gtt Anabolic Agents adverse effects Anabolic steroids Bodybuilders Drug use Doping in Sports Doping in sports Risk Assessment Weight Lifting physiology Weight Lifting psychology Doping (DE-588)4126002-8 gnd |
| subject_GND | (DE-588)4126002-8 |
| title | Bodybuilding, drugs and risk |
| title_auth | Bodybuilding, drugs and risk |
| title_exact_search | Bodybuilding, drugs and risk |
| title_full | Bodybuilding, drugs and risk Lee F. Monaghan |
| title_fullStr | Bodybuilding, drugs and risk Lee F. Monaghan |
| title_full_unstemmed | Bodybuilding, drugs and risk Lee F. Monaghan |
| title_short | Bodybuilding, drugs and risk |
| title_sort | bodybuilding drugs and risk |
| topic | Anabole steroïden gtt Anabolisants Bodybuilding gtt Culturistes - Usage des médicaments Dopage dans les sports Drugsgebruik gtt Lichamelijkheid gtt Sociale identiteit gtt Anabolic Agents adverse effects Anabolic steroids Bodybuilders Drug use Doping in Sports Doping in sports Risk Assessment Weight Lifting physiology Weight Lifting psychology Doping (DE-588)4126002-8 gnd |
| topic_facet | Anabole steroïden Anabolisants Bodybuilding Culturistes - Usage des médicaments Dopage dans les sports Drugsgebruik Lichamelijkheid Sociale identiteit Anabolic Agents adverse effects Anabolic steroids Bodybuilders Drug use Doping in Sports Doping in sports Risk Assessment Weight Lifting physiology Weight Lifting psychology Doping |
| work_keys_str_mv | AT monaghanleef bodybuildingdrugsandrisk |